Multiple Assemblies exist for SMTL entry 4fw4
Crystal Structure of the LpxC in complex with N-[(1S,2R)-2-HYDROXY-1-(HYDROXYCARBAMOYL)PROPYL]-4-(4-PHENYLBUTA-1,3-DIYN-1-YL)BENZAMIDE inhibitor; X-RAY DIFFRACTION 2.19 Å

	SMTL ID 4fw4.1 Ligands ZINC ION; N-[(1S,2R)-2-hydroxy-1-(hydroxycarbamoyl)propyl]-4-(4-phenylbuta-1,3-diyn-1-yl)benzamide Polypeptides UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase Oligo-state monomer
	SMTL ID 4fw4.2 Ligands ZINC ION; N-[(1S,2R)-2-hydroxy-1-(hydroxycarbamoyl)propyl]-4-(4-phenylbuta-1,3-diyn-1-yl)benzamide; GLYCEROL Polypeptides UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase Oligo-state monomer
	SMTL ID 4fw4.3 Ligands ZINC ION; N-[(1S,2R)-2-hydroxy-1-(hydroxycarbamoyl)propyl]-4-(4-phenylbuta-1,3-diyn-1-yl)benzamide; GLYCEROL; ACETATE ION Polypeptides UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase Oligo-state monomer
	SMTL ID 4fw4.4 Ligands ZINC ION; N-[(1S,2R)-2-hydroxy-1-(hydroxycarbamoyl)propyl]-4-(4-phenylbuta-1,3-diyn-1-yl)benzamide; GLYCEROL Polypeptides UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase Oligo-state monomer